期刊文献+

16例三阴性乳腺癌的临床诊治与分析 被引量:1

下载PDF
导出
摘要 目的分析三阴性乳腺癌的临床特点。方法对2002年1月—2008年12月收治的16例三阴性乳腺癌患者的临床资料及预后进行回顾性分析,研究其特点。结果 16例三阴性乳腺癌患者占同期乳腺癌患者(121例)的13.2%,45岁以上患者占87.5%(14/16),绝经后患者占68.8%(11/16),93.8%(15/16)的患者肿瘤<5 cm,腋窝淋巴结阴性患者占62.5%(10/16),病理类型以浸润性导管癌为主,占93.8%(15/16)。7例患者出现复发或转移,其中5例死亡。2/7例同时出现2个部位以上的复发或转移。术后1年内出现复发或转移的患者共5例,另2例在术后2年内发生了转移。结论三阴性乳腺癌复发转移快、病死率高,并且治疗手段有限。对其诊治应严格而规范。
出处 《河北医科大学学报》 CAS 2010年第10期1238-1239,共2页 Journal of Hebei Medical University
  • 相关文献

参考文献4

二级参考文献41

  • 1Raha EA, Elsayed ME, Green AR, et al. Prognostic markers in triple - negative breast cancer [ J]. Cancer, 2007, 109 (1) :25 -32.
  • 2Morris GJ,Naidu S,Topham AK,et al. Differences in breast carcinoma characteristics in newly diagnosed African - American and Caucasian patients : A single - institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database [ J ]. Cancer,2007,110(4) :876 - 884.
  • 3Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets [ J]. PNAS ,2003,100:8418 - 8423.
  • 4Reis - Filho JS, Tutt AN. Triple negative breast cancer: a critical review [ J ]. Histopathology, 2008,52 ( 1 ) : 108 - 118.
  • 5Kim M J, Ro JY, Ahn SH, et al. Clinicopathologicsignificance of the basal - like subtype of breast cancer: A comparison with hormone receptor and Her- 2/neu- overexpressing phenotypes [ J ]. Hum Pathol,2006,37 (9) : 1217 - 1226.
  • 6Sara M, Bando Y, Takahashi N, et al. Screening for basal marker expression is necessary for decision of therapeutic strategy for triple - negative breast cancer [ J ]. J Surg Oncol,2008,97( 1 ) :30 -34.
  • 7Dent R, Trudeau M, Pritchard KJ, et al. Triple negative breast cancer: clinical features and patterns of recurrence [ J]. Clin Cancer Res ,2007,13:4429 - 4434.
  • 8Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes ,and survival in the Carolina Breast Cancer Study [ J]. JAMA ,2006 ,295 (21) :24922 - 24502.
  • 9Tischkowitz M, Brunet JS, Begin LR, et al. Use of immunohistochemical markers can refine prognosis in triple negative breast cancer[J]. BMC Cancer,2007,7 : 134.
  • 10Carey LA,Dees EC,Sawyer L, et al. The triple negative paradox:primary tumor chemosensitivity of breast cancer subtypes[ J]. Clin Cancer Res, 2007, 13 (8) : 2329 - 2334.

共引文献61

同被引文献14

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部